| 000 | 01383 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250511212036.0 | ||
| 264 | 0 | _c19910306 | |
| 008 | 199103s 0 0 eng d | ||
| 022 | _a0002-8703 | ||
| 024 | 7 |
_a10.1016/0002-8703(91)90730-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMohler, E R | |
| 245 | 0 | 0 |
_aConservative management complications after thrombolytic therapy. _h[electronic resource] |
| 260 |
_bAmerican heart journal _cFeb 1991 |
||
| 300 |
_a591-3 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAngioplasty, Balloon, Coronary |
| 650 | 0 | 4 |
_aAspirin _xadministration & dosage |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeparin _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aThrombolytic Therapy _xadverse effects |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xadministration & dosage |
| 700 | 1 | _aStark, K S | |
| 700 | 1 | _aKent, K M | |
| 773 | 0 |
_tAmerican heart journal _gvol. 121 _gno. 2 Pt 1 _gp. 591-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0002-8703(91)90730-6 _zAvailable from publisher's website |
| 999 |
_c1905515 _d1905515 |
||